Technical Analysis for TNDM - Tandem Diabetes Care, Inc.

Grade Last Price % Change Price Change
grade B 49.36 0.74% 0.36
TNDM closed down 2.43 percent on Wednesday, February 20, 2019, on 82 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Feb 26

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical TNDM trend table...

Date Alert Name Type % Chg
Feb 20 Stochastic Sell Signal Bearish 0.73%
Feb 20 New Uptrend Bullish 0.73%
Feb 20 Upper Bollinger Band Walk Strength 0.73%
Feb 20 Multiple of Ten Bearish Other 0.73%
Feb 20 Overbought Stochastic Strength 0.73%
Feb 20 Upper Bollinger Band Touch Strength 0.73%
Feb 19 Slingshot Bullish Bullish Swing Setup -1.71%
Feb 19 Upper Bollinger Band Walk Strength -1.71%
Feb 19 Multiple of Ten Bullish Other -1.71%
Feb 19 Above Upper BB Strength -1.71%

Older signals for TNDM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes. The company's products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides users, their caregivers, and their healthcare providers a fast, easy, and visual way to display therapy management data from the pump and supported blood glucose meters. It sells its products in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Insulin Endocrinology Diabetes Care Insulin Delivery Diabetes Management Diabetes Mellitus Type 1 Insulin Dependent Diabetes
Is TNDM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.55
52 Week Low 2.78
Average Volume 1,471,781
200-Day Moving Average 32.5021
50-Day Moving Average 40.2268
20-Day Moving Average 44.644
10-Day Moving Average 46.304
Average True Range 2.5879
ADX 25.0
+DI 35.4214
-DI 16.5263
Chandelier Exit (Long, 3 ATRs ) 44.2663
Chandelier Exit (Short, 3 ATRs ) 48.2237
Upper Bollinger Band 50.6473
Lower Bollinger Band 38.6407
Percent B (%b) 0.86
BandWidth 26.894096
MACD Line 2.4804
MACD Signal Line 1.9532
MACD Histogram 0.5272
Fundamentals Value
Market Cap 246.15 Million
Num Shares 5.02 Million
EPS -25.15
Price-to-Earnings (P/E) Ratio -1.95
Price-to-Sales 0.17
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.53
Resistance 3 (R3) 52.79 51.89 51.94
Resistance 2 (R2) 51.89 50.99 51.75 51.74
Resistance 1 (R1) 50.44 50.43 49.99 50.18 51.55
Pivot Point 49.54 49.54 49.31 49.40 49.54
Support 1 (S1) 48.09 48.64 47.64 47.83 46.45
Support 2 (S2) 47.19 48.08 47.05 46.26
Support 3 (S3) 45.74 47.19 46.06
Support 4 (S4) 45.48